Newsmeme!
Discover News you didn't know existed
FRAMINGHAM - GTC Biotherapeutics Inc. has licensed rights from Merrimack Pharmaceuticals Inc. to develop a protein for the treatment of autoimmune disorders, an agreement that includes GTC taking control of goats it developed in recent years for Merrimack.
FRIDAY Ehrnfelt Recreation and Senior Center, 18100 Royalton Road, Strongsville, (440) 580-3275. 50+ Singles Mingle, 7:30 p.m. West Side Irish-American Club, 8559 Jennings Road, Olmsted Township. Free concert in the pub 7:30 p.m. featuring Folktic. Food served from 6-9...
DUBLIN----Amarin Corporation plc today announced that it has reached agreement with the U.S. Food and Drug Administration under a Special Protocol Assessment for its planned Phase 3 clinical trial of AMR101 in patients with mixed dyslipidemia.
FORT HOOD – A 230-mile road trip may not be a challenge for most, but it was for Michelle Huvar. She is bound to a wheelchair by myasthenia gravis, rheumatoid arthritis and fibromyalgia, but she wanted to be at Fort Hood for her husband when he returned from a 15-month deployment to Iraq.
FRAMINGHAM, Mass.----GTC Biotherapeutics, Inc. has obtained exclusive worldwide rights to the development and commercialization of recombinant human alpha-fetoprotein , including the recombinant, non-glycosylated version of rhAFP known as MM-093, for the treatment of autoimmune diseases from Merrimack Pharmaceuticals.
DUBLIN----Amarin Corporation plc announced today that on July 6, 2009, the Company received a written notification from the Nasdaq Stock Market stating that it is not in compliance with the filing requirements for continued listing under Nasdaq Marketplace Rule 5250.
DUBLIN----Amarin Corporation plc announced today that it has entered into a non-binding term sheet with certain existing investors relating to the proposed private placement of American Depositary Shares for up to $55 million over two or more closings.
TOKYO, July 7 (Reuters) - Astellas Pharma Inc <4503.T>, Japan's second-largest drugmaker, said on Tuesday it has won approval to sell its key transplant drug Prograf in Japan as a treatment for severe ulcerative colitis, a form of intestinal inflammation.
Here is a list of self-help groups beginning Tuesday, July 7, 2009.
SUPPORT GROUPS
Related News Resources:
> HGH News
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |